Results 211 to 220 of about 11,142,973 (358)

Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases

Immunological Reviews, 2017
Si Ming Man, Rajendra Karki, T. Kanneganti   +2 more
semanticscholar   +1 more source

Predicting Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Accurate localization of epileptogenic tubers (ETs) in patients with tuberous sclerosis complex (TSC) is essential but challenging, as these tubers lack distinct pathological or genetic markers to differentiate them from other cortical tubers.
Tinghong Liu, Qi Wang, Suhui Kuang, Dezhi Cao, Ping Ding, Shaohui Zhang, Haihua Wei, Zhirong Wei, Jinshan Xu, Xinyu Huang, Bing Liu, Shuli Liang   +11 more
wiley   +1 more source

The Infectious Diseases Orchestrator: Embracing AI Literacy in the Agentic Era. [PDF]

Open Forum Infect Dis
Hanna JJ, Medford RJ.
europepmc   +1 more source

Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America [PDF]

, 2013
Judith A. Aberg, Joel E. Gallant, Khalil G. Ghanem, Patricia Emmanuel, Barry S. Zingman, Michael A. Horberg   +5 more
openalex   +1 more source

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Clinical Infectious Diseases, 2009
P. Pappas, C. Kauffman, D. Andes, D. Benjamin, T. Calandra, J. Edwards, S. Filler, J. Fisher, B. Kullberg, L. Ostrosky-Zeichner, A. Reboli, J. Rex, T. Walsh, J. Sobel   +13 more
semanticscholar   +1 more source

Life‐Threatening Bradycardia in Anti‐NMDA‐Receptor Encephalitis and a Novel Use for Permanent Pacing

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Pediatric anti‐NMDA receptor encephalitis (pNMDARE) is an autoantibody‐mediated disorder that can cause severe autonomic dysfunction, including symptomatic bradycardia and asystole. Dysautonomia can last for years, making it very challenging to manage.
Sarah Tucker, Abhijit Das, Andres Jimenez, Areeba Basit, Yike Jiang, Emily A. Smitherman, Heather Van Mater, Taylor Howard, Alexander J. Sandweiss, Kristen S. Fisher   +9 more
wiley   +1 more source

Healthcare-related Infectious Diseases

Emerging Infectious Diseases, 2004
Naomi Swanson, Clara Sue Ross, Kevin Fennelly   +2 more
doaj   +1 more source

Editorial: Methods in pediatric infectious diseases 2024. [PDF]

Front Pediatr
Kosmas I, Mota GA, Shi Z.
europepmc   +1 more source

Emerging infectious diseases [PDF]

Public Health Research and Practice, 2016
openaire   +2 more sources

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source